Follow us:Follow Us on Twitter Like Us on Facebook Follow Us on Google+ Watch videos on our Youtube channel
Dennis Jen-Ming Huang, PhD
Project Scientist Email: firstname.lastname@example.orgLearn More
Dennis Jen-Ming Huang, PhD, is a postdoctoral fellow of medicine at Cedars-Sinai. His research focuses on network analyses of metastatic prostate cancer with focus on molecular mechanisms underlying osteoblastic and osteolytic related gene expression by human prostate cancer cell lines.
Ruoxiang Wang, MD, PhD
Associate Professor Email: email@example.comLearn More
Ruoxiang Wang, MD, PhD, is an associate professor of medicine at both Cedars-Sinai and UCLA. He characterizes the stem cell phenotypes in prostate cancer cells, defines the fusion between prostate cancer epithelial and prostate stromal cells and explores the use of stem cells as therapeutic targeting agent.
Boyang (Jason) Wu, PhD
Project Scientist Email: firstname.lastname@example.orgLearn More
Boyand (Jason) Wu, PhD, discovered an exciting novel therapeutic target, monoamine oxidase inhibitor (MAO). In the Chung Laboratory, he characterizes the mechanism of hypoxia regulating MAO expression and near-infrared dye uptake in prostate cancer cells.
Lijuan Yin, MD, PhD
Postdoctoral Fellow Email: email@example.comLearn More
Lijuan Yin, MD, PhD, has a research project focused on establishing bone- and brain-metastases models of prostate and breast cancers. She also helps in the analysis and interpretation of histopathology and gene expression of experimental and clinical cancer specimens.
Haiyen E. Zhau, PhD
Professor Email: firstname.lastname@example.orgLearn More
Haiyen E. Zhau, PhD, is a professor of medicine at Cedars-Sinai. Her research interest is cancer plasticity and epithelial-mesenchymal transition. She developed multiplex imaging technology at the single cell level for cancer prognosis, diagnosis and treatment follow-up, and for gene expression profiling of CTC in prostate cancer cell models and clinical specimens.